Prognostic Value of Pretreatment Serum Cystatin C Level in Nasopharyngeal Carcinoma Patients in the Intensity-modulated Radiotherapy Era.

Xi-Rong TanSheng-Yan HuangSha GongYang ChenXiao-Jing YangQing-Mei HeShi-Wei HeNa Liu Ying-Qing Li

Published in: OncoTargets and therapy (2021)

Our results revealed that high serum cystatin C level before antitumor treatment can predict clinical outcomes of NPC patients treated with IMRT, and it can guide clinicians to formulate more personalized therapy for NPC patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
radiation therapy
early stage
radiation induced